Assenagon Asset Management S.A. Buys 165,797 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Assenagon Asset Management S.A. lifted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 67.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 411,012 shares of the company’s stock after acquiring an additional 165,797 shares during the quarter. Assenagon Asset Management S.A.’s holdings in DocuSign were worth $36,966,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Thrivent Financial for Lutherans bought a new stake in DocuSign in the second quarter valued at approximately $115,795,000. Pacer Advisors Inc. boosted its stake in shares of DocuSign by 77.9% in the 2nd quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company’s stock valued at $188,318,000 after purchasing an additional 1,541,816 shares during the last quarter. KBC Group NV increased its position in shares of DocuSign by 209.8% during the third quarter. KBC Group NV now owns 1,156,874 shares of the company’s stock worth $71,830,000 after buying an additional 783,419 shares during the period. Skandinaviska Enskilda Banken AB publ raised its stake in DocuSign by 151.3% during the second quarter. Skandinaviska Enskilda Banken AB publ now owns 865,872 shares of the company’s stock worth $46,324,000 after buying an additional 521,292 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec lifted its holdings in DocuSign by 42.4% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,459,580 shares of the company’s stock valued at $90,625,000 after buying an additional 434,312 shares during the period. 77.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other DocuSign news, Director Peter Solvik sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $91.26, for a total transaction of $912,600.00. Following the completion of the sale, the director now directly owns 150,253 shares of the company’s stock, valued at approximately $13,712,088.78. The trade was a 6.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Daniel D. Springer sold 581,588 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the transaction, the director now owns 906,430 shares in the company, valued at $87,959,967.20. This represents a 39.08 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 693,537 shares of company stock worth $66,575,817 in the last quarter. Insiders own 1.66% of the company’s stock.

DocuSign Trading Down 0.2 %

DOCU opened at $91.16 on Friday. The company has a market cap of $18.42 billion, a price-to-earnings ratio of 18.80, a PEG ratio of 8.17 and a beta of 0.88. The company’s fifty day moving average price is $88.26 and its two-hundred day moving average price is $69.77. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Hsbc Global Res upgraded DocuSign to a “moderate sell” rating in a report on Friday, December 6th. Morgan Stanley upped their target price on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research report on Friday, December 6th. UBS Group lifted their target price on DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. JMP Securities restated a “market outperform” rating and set a $124.00 price target on shares of DocuSign in a report on Tuesday, January 7th. Finally, Robert W. Baird lifted their price objective on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $92.45.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.